Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2018-02-28 (8 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: LANMEUR ([ND]), None
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE BODENES - IAUCH is a French company
founded 8 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in LANMEUR ([ND]),
this company of category PME
shows in 2023 a revenue of 3.6 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE BODENES - IAUCH (SIREN 837812098)
Indicator
2025
2024
2023
2022
2021
2019
Revenue
N/C
N/C
3 631 017 €
N/C
N/C
N/C
Net income
302 435 €
253 021 €
346 928 €
415 474 €
252 483 €
159 333 €
EBITDA
N/C
N/C
508 271 €
N/C
N/C
N/C
Net margin
N/C
N/C
9.6%
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE BODENES - IAUCH generates positive net income of 302 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2025: 159 k€ -> 302 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
302 435 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 67%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 56%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
67.438%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
55.903%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2021
2022
2023
2024
2025
Debt ratio
805.339
321.795
197.236
127.177
91.485
67.438
Financial autonomy
10.341
22.515
31.347
41.499
49.032
55.903
Repayment capacity
None
None
None
5.249
None
None
Cash flow / Revenue
None%
None%
None%
10.239%
None%
None%
Sector positioning
Debt ratio
67.442025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average-9 pts over 3 years
In 2025, the debt ratio of PHARMACIE BODENES - IAUCH (67.44) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
55.9%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Good+12 pts over 3 years
In 2025, the financial autonomy of PHARMACIE BODENES - IAUCH (55.9%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
5.25 years2023
2023
Q1: 0.95 years
Med: 3.59 years
Q3: 7.48 years
Average
In 2023, the repayment capacity of PHARMACIE BODENES - IAUCH (5.25) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 250.74. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2019
2021
2022
2023
2024
2025
Liquidity ratio
220.336
245.192
269.6
273.763
225.004
250.736
Interest coverage
None
None
None
5.255
None
None
Sector positioning
Liquidity ratio
250.742025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Good
In 2025, the liquidity ratio of PHARMACIE BODENES - IAUCH (250.74) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
5.25x2023
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Good
In 2023, the interest coverage of PHARMACIE BODENES - IAUCH (5.2x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE BODENES - IAUCH
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2021
2022
2023
2024
2025
Operating WCR
0 €
0 €
0 €
439 099 €
0 €
0 €
Inventory turnover (days)
0
0
0
36
0
0
Customer payment term (days)
0
0
0
4
0
0
Supplier payment term (days)
0
0
0
26
0
0
Positioning of PHARMACIE BODENES - IAUCH in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE BODENES - IAUCH is estimated at
4 804 215 €
(range 3 260 163€ - 7 538 476€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
3260k€4804k€7538k€
4 804 215 €Range: 3 260 163€ - 7 538 476€
NAF 5 année 2025
Valuation method used
Net Income Multiple
302 435 €
×
15.9x
=4 804 216 €
Range: 3 260 164€ - 7 538 476€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE BODENES - IAUCH with other companies in the same sector:
Frequently asked questions about PHARMACIE BODENES - IAUCH
What is the revenue of PHARMACIE BODENES - IAUCH ?
The revenue of PHARMACIE BODENES - IAUCH in 2023 is 3.6 M€.
Is PHARMACIE BODENES - IAUCH profitable?
Yes, PHARMACIE BODENES - IAUCH generated a net profit of 302 k€ in 2025.
Where is the headquarters of PHARMACIE BODENES - IAUCH ?
The headquarters of PHARMACIE BODENES - IAUCH is located in LANMEUR ([ND]).
Where to find the tax return of PHARMACIE BODENES - IAUCH ?
The tax return of PHARMACIE BODENES - IAUCH is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE BODENES - IAUCH operate?
PHARMACIE BODENES - IAUCH operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart